Table 4 Summary of mutational analysis in NSCLC patients with E2A-PBX1 fusion transcripts
From: Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
Total (%) | K-P-E- | K + P-E- | K-P + E- | K + P + E- | K-P + E+ | K-P-E+ | K + P-E+ | K + P + E+ | ||
|---|---|---|---|---|---|---|---|---|---|---|
Total | 22 (100) | 12 (54.5) | 7 (31.8) | 1 (4.5) | 1 (4.5) | 1 (4.5) | ||||
Gender | F | 15 (100) | 7 (46.7) | 5 (33.3) | 1 (6.7) | 1 (6.7) | 1 (6.7) | |||
M | 7 (100) | 5 (71.4) | 2 (28.6) | |||||||
Race | Caucasian | 16 (100) | 8 (50.0) | 5 (31.3) | 1 (6.3) | 1 (6.3) | 1 (6.3) | |||
Asian | 3 (100) | 2 (66.7) | 1 (33.3) | |||||||
Middle eastern | 1 (100) | 1 (100) | ||||||||
Hispanic | 2 (100) | 1(50.0) | 1 (50.0) | |||||||
Smoking status | NS | 4 (100) | 4 (100) | |||||||
S | 18 (100) | 8 (44.4) | 7 (38.9) | 1 (5.6) | 1 (5.6) | 1 (5.6) | ||||
Stage | I | 12 (100) | 8 (66.7) | 3 (25.0) | 1 (8.3) | |||||
II | 2 (100) | 1 (50.0) | 1 (50.0) | |||||||
III | 5 (100) | 2 (40.0) | 2 (40.0) | 1 (20.0) | ||||||
IV | 3 (100) | 1 (33.3) | 1 (33.3) | 1 (33.3) | ||||||
Histology | AIS | 16 (100) | 8 (50.0) | 5 (31.3) | 1 (6.3) | 1 (6.3) | 1 (6.3) | |||
Invasive Adc | 5 (100) | 3 (60.0) | 2 (40.0) | |||||||
LCC | 1 (100) | 1 (100) |